P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy

Although electroconvulsive therapy (ECT) is among the most effective treatment options for pharmacoresistant major depressive disorder (MDD), some patients still remain refractory to standard ECT practise. Thus, there is a need for markers reliably predicting ECT non/response. In our study, we have...

Descripción completa

Detalles Bibliográficos
Autores principales: Neyazi, Alexandra, Theilmann, Wiebke, Brandt, Claudia, Rantamäki, Tomi, Matsui, Nobuaki, Rhein, Mathias, Kornhuber, Johannes, Bajbouj, Malek, Sperling, Wolfgang, Bleich, Stefan, Frieling, Helge, Löscher, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802592/
https://www.ncbi.nlm.nih.gov/pubmed/29353887
http://dx.doi.org/10.1038/s41398-017-0077-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802592/
https://www.ncbi.nlm.nih.gov/pubmed/29353887
http://dx.doi.org/10.1038/s41398-017-0077-3

Ejemplares similares